Prenetics Global Limited (NASDAQ:PRENW) Short Interest Update

Prenetics Global Limited (NASDAQ:PRENW) was the recipient of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 27,675 shares, a decrease of 96.5% from the July 15th total of 787,526 shares. Based on an average daily volume of 29,679 shares, the short-interest ratio is currently 0.9 days.

Prenetics Global Trading Down 4.8%

Prenetics Global stock traded down $0.00 during mid-day trading on Tuesday, hitting $0.01. 11,420 shares of the company’s stock were exchanged, compared to its average volume of 39,161. Prenetics Global has a 1-year low of $0.01 and a 1-year high of $0.04. The stock has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.02.

Prenetics Global Company Profile

Prenetics Global (NASDAQ: PRENW) is a molecular diagnostics and preventive genomics company that develops and delivers DNA-based tests and diagnostic solutions. The company’s offerings include direct-to-consumer health profiling services, clinical genetic tests, and pathogen screening assays. By combining advanced laboratory processes with digital tools, Prenetics aims to provide insights into genetic risk factors, nutrition and fitness optimization, and early disease detection.

Prenetics operates a portfolio of consumer genomics brands, including DNAFit and CircleDNA, which offer personalized reports on wellness, exercise, nutrition, and inherited health traits.